Comment
doi: 10.1016/S1473-3099(15)00534-4.
Epub 2015 Dec 23.
Ebola vaccines: we have options
Affiliations
- PMID: 26725448
- DOI: 10.1016/S1473-3099(15)00534-4
Item in Clipboard
Comment
Ebola vaccines: we have options
Lancet Infect Dis.
2016 Mar.
No abstract available
Comment on
-
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.Lancet Infect Dis. 2016 Mar;16(3):311-20. doi: 10.1016/S1473-3099(15)00486-7. Epub 2015 Dec 23. Lancet Infect Dis. 2016. PMID: 26725450 Clinical Trial.
Similar articles
-
Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.JAMA. 2017 Mar 14;317(10):1075-1077. doi: 10.1001/jama.2016.20644. JAMA. 2017. PMID: 28291882 Clinical Trial. No abstract available.
-
Ebola vaccine is safe and immunogenic, results show.BMJ. 2015 Jan 29;350:h524. doi: 10.1136/bmj.h524. BMJ. 2015. PMID: 25633684 No abstract available.
-
Adenovirus-vectored Ebola vaccines.Expert Rev Vaccines. 2015;14(10):1347-57. doi: 10.1586/14760584.2015.1077122. Epub 2015 Aug 11. Expert Rev Vaccines. 2015. PMID: 26289977 Review.
-
Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.Antiviral Res. 2015 Apr;116:17-9. doi: 10.1016/j.antiviral.2015.01.001. Epub 2015 Jan 14. Antiviral Res. 2015. PMID: 25596432
-
Immunology of protection from Ebola virus infection.Sci Transl Med. 2015 May 6;7(286):286ps11. doi: 10.1126/scitranslmed.aaa8202. Sci Transl Med. 2015. PMID: 25947159 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
